Vogt L - Search Results

1

Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.

Meuleman Y, Ten Brinke L, Kwakernaak AJ, Vogt L, Rotmans JI, Bos WJ, van der Boog PJ, Navis G, van Montfrans GA, Hoekstra T, Dekker FW, van Dijk S. Meuleman Y, et al. Among authors: vogt l. Int J Behav Med. 2015 Aug;22(4):530-9. doi: 10.1007/s12529-014-9447-x. Int J Behav Med. 2015. PMID: 25298022

2

Renoprotection: a matter of blood pressure reduction or agent-characteristics?

Vogt L, Navis G, de Zeeuw D. Vogt L, et al. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S202-7. doi: 10.1097/01.asn.0000032489.33856.53. J Am Soc Nephrol. 2002. PMID: 12466315 Review.

3

Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.

Vogt L, Laverman GD, Dullaart RP, Navis G. Vogt L, et al. Nephrol Dial Transplant. 2004 Jan;19(1):5-8. doi: 10.1093/ndt/gfg497. Nephrol Dial Transplant. 2004. PMID: 14671028 Review. No abstract available.

4

Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?

Vogt L, Kocks MJ, Laverman GD, Navis G. Vogt L, et al. Minerva Med. 2004 Oct;95(5):395-409. Minerva Med. 2004. PMID: 15467515 Review.

5

Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?

Vogt L, Navis G, de Zeeuw D. Vogt L, et al. J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S53-7. doi: 10.1681/asn.2004121074. J Am Soc Nephrol. 2005. PMID: 15938035 Clinical Trial.

6

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Vogt L, et al. J Am Soc Nephrol. 2008 May;19(5):999-1007. doi: 10.1681/ASN.2007060693. Epub 2008 Feb 13. J Am Soc Nephrol. 2008. PMID: 18272844 Free PMC article. Clinical Trial.

7

Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.

Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G. Waanders F, et al. Among authors: vogt l. Am J Kidney Dis. 2009 Jan;53(1):16-25. doi: 10.1053/j.ajkd.2008.07.021. Epub 2008 Sep 27. Am J Kidney Dis. 2009. PMID: 18823687 Free PMC article. Clinical Trial.

8

Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.

Vogt L, de Zeeuw D, Woittiez AJ, Navis G. Vogt L, et al. Nephrol Dial Transplant. 2009 Apr;24(4):1182-9. doi: 10.1093/ndt/gfn644. Epub 2008 Nov 26. Nephrol Dial Transplant. 2009. PMID: 19037084 Clinical Trial.

9

Time for a comeback of NSAIDs in proteinuric chronic kidney disease?

Vogt L, Laverman GD, Navis G. Vogt L, et al. Neth J Med. 2010 Dec;68(12):400-7. Neth J Med. 2010. PMID: 21209465 Free article. Review.

10

Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

Slagman MC, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Laverman GD, Goldschmeding R, Navis G. Slagman MC, et al. Among authors: vogt l. Clin J Am Soc Nephrol. 2011 Aug;6(8):1845-50. doi: 10.2215/CJN.08190910. Epub 2011 Jul 22. Clin J Am Soc Nephrol. 2011. PMID: 21784839 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters